Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8789963 | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 Pages |
Abstract
Our results suggest that mTOR pathway activity is increased in tumor and sustained in its microenvironment in patients with adverse pathologic findings at cystectomy. These findings suggest the relevance of targeting this pathway in bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Brian R. M.D., Funda M.D., Lisha M.S., Bruce M.D., Roland M.D., Peter C. M.D., Joost L. M.D., Ph.D., Marc M.D., Elai Ph.D., James M.B.B.S., M.Sc., Ewan A. Ph.D., Bas W.G. M.D., Ph.D., Michiel S. M.D., Ph.D., Andrew C. M.D., Jonathan L. M.D., M.S.,